KV heterologous treatment significantly increased Th1 CD4+ T cells (% and numbers) in the tumor, while other T-helper subtypes (Th2, Th17, Tregs) were reduced in frequencies, but not in absolute numbers. Here, CD4 is linked to neoplasm.